152 related articles for article (PubMed ID: 24814647)
1. The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials.
Liu Y; Tian T; Zhang H; Gao L; Zhou X
Atherosclerosis; 2014 Jul; 235(1):31-5. PubMed ID: 24814647
[TBL] [Abstract][Full Text] [Related]
2. Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.
Title LM; Ur E; Giddens K; McQueen MJ; Nassar BA
Vasc Med; 2006 May; 11(2):101-9. PubMed ID: 16886840
[TBL] [Abstract][Full Text] [Related]
3. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.
Title LM; Cummings PM; Giddens K; Genest JJ; Nassar BA
J Am Coll Cardiol; 2000 Sep; 36(3):758-65. PubMed ID: 10987596
[TBL] [Abstract][Full Text] [Related]
4. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults.
Carlsson CM; Pharo LM; Aeschlimann SE; Mitchell C; Underbakke G; Stein JH
Am Heart J; 2004 Sep; 148(3):E11. PubMed ID: 15389247
[TBL] [Abstract][Full Text] [Related]
5. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering.
Doshi SN; McDowell IF; Moat SJ; Payne N; Durrant HJ; Lewis MJ; Goodfellow J
Circulation; 2002 Jan; 105(1):22-6. PubMed ID: 11772871
[TBL] [Abstract][Full Text] [Related]
6. Folate improves endothelial function in patients with coronary heart disease.
Doshi S; McDowell I; Moat S; Lewis M; Goodfellow J
Clin Chem Lab Med; 2003 Nov; 41(11):1505-12. PubMed ID: 14656033
[TBL] [Abstract][Full Text] [Related]
7. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease.
Yilmaz H; Sahin S; Sayar N; Tangurek B; Yilmaz M; Nurkalem Z; Onturk E; Cakmak N; Bolca O
Acta Cardiol; 2007 Dec; 62(6):579-85. PubMed ID: 18214123
[TBL] [Abstract][Full Text] [Related]
8. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.
Potter K; Hankey GJ; Green DJ; Eikelboom J; Jamrozik K; Arnolda LF
BMC Cardiovasc Disord; 2008 Sep; 8():24. PubMed ID: 18803866
[TBL] [Abstract][Full Text] [Related]
9. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease.
Thambyrajah J; Landray MJ; Jones HJ; McGlynn FJ; Wheeler DC; Townend JN
J Am Coll Cardiol; 2001 Jun; 37(7):1858-63. PubMed ID: 11401123
[TBL] [Abstract][Full Text] [Related]
10. Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia.
Dinckal MH; Aksoy N; Aksoy M; Davutoglu V; Soydinc S; Kirilmaz A; Dinckal N; Akdemir I
Acta Cardiol; 2003 Oct; 58(5):389-96. PubMed ID: 14609303
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials.
Qin X; Huo Y; Xie D; Hou F; Xu X; Wang X
Clin Nutr; 2013 Oct; 32(5):722-7. PubMed ID: 23313356
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
Wustmann K; Klaey M; Burow A; Shaw SG; Hess OM; Allemann Y
Cardiovasc Ther; 2012 Oct; 30(5):277-86. PubMed ID: 21884007
[TBL] [Abstract][Full Text] [Related]
13. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial.
van Dijk RA; Rauwerda JA; Steyn M; Twisk JW; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2072-9. PubMed ID: 11742887
[TBL] [Abstract][Full Text] [Related]
14. Effect of folic acid on endothelial function following acute myocardial infarction.
Moens AL; Claeys MJ; Wuyts FL; Goovaerts I; Van Hertbruggen E; Wendelen LC; Van Hoof VO; Vrints CJ
Am J Cardiol; 2007 Feb; 99(4):476-81. PubMed ID: 17293188
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.
Miller ER; Juraschek S; Pastor-Barriuso R; Bazzano LA; Appel LJ; Guallar E
Am J Cardiol; 2010 Aug; 106(4):517-27. PubMed ID: 20691310
[TBL] [Abstract][Full Text] [Related]
16. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
17. Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
Qin X; Xu M; Zhang Y; Li J; Xu X; Wang X; Xu X; Huo Y
Atherosclerosis; 2012 Jun; 222(2):307-13. PubMed ID: 22209480
[TBL] [Abstract][Full Text] [Related]
18. Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects.
Woodman RJ; Celermajer DE; Thompson PL; Hung J
Clin Sci (Lond); 2004 Apr; 106(4):353-8. PubMed ID: 14641105
[TBL] [Abstract][Full Text] [Related]
19. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.
Mangoni AA; Sherwood RA; Asonganyi B; Swift CG; Thomas S; Jackson SH
Am J Hypertens; 2005 Feb; 18(2 Pt 1):220-6. PubMed ID: 15752950
[TBL] [Abstract][Full Text] [Related]
20. Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials.
Clarke R
Indian Heart J; 2000; 52(7 Suppl):S59-64. PubMed ID: 11339443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
